Literature DB >> 26228108

Diameter of Solid Tumor Component Alone Should be Used to Establish T Stage in Lung Adenocarcinoma.

Bryan M Burt1,2, Ann N Leung3, Masahiro Yanagawa4, William Chen3, Shawn S Groth5, Chuong D Hoang3, Viswam S Nair3, Joseph B Shrager3.   

Abstract

PURPOSE: The computed tomographic (CT) appearance of so-called ground glass components within lung adenocarcinomas correlate with noninvasive tumor histology, and solid radiographic components correlate with invasive histology. We hypothesized that T stage might be more accurately applied by considering the solid component nodule diameter rather than total nodule diameter.
METHODS: We identified 74 patients with a solitary lung adenocarcinoma who underwent resection without receiving neoadjuvant therapy. Maximum total diameter and solid diameter of the nodules were measured on CT scans performed within 3 months of surgery. Cox proportional hazard modeling and Kaplan-Meier analyses were performed to determine whether total nodule diameter or solid component diameter was more predictive of overall survival.
RESULTS: Thirty-three patients (45 %) had a solid nodule and 41 patients (55 %) had a part-solid nodule. Most patients were white (59 %) and female (69 %), and 42 % had never smoked. Seventy-four percent underwent lobectomy and 23 % sublobar resection. Sixty-six percent had pathologic stage I disease, 22 % stage II, and 12 % stage IIIA. Mean ± SD total and solid nodule diameters were 32.1 ± 17.5 and 24.8 ± 18.0 mm, respectively (p = 0.01). Among patients with part-solid nodules, multivariate modeling incorporating significant univariate predictors of survival (age, gender, procedure, N descriptor) revealed that maximum solid diameter was associated with overall survival (hazard ratio 1.4, p = 0.01), while maximum total diameter was not.
CONCLUSIONS: In a largely non-Asian cohort undergoing resection for adenocarcinoma, radiographic diameter of the solid component of a part-solid lesion on CT predicts overall survival better than total lesion diameter. These data provide further evidence to support altering the T descriptor for lung adenocarcinoma for part-solid nodules.

Entities:  

Mesh:

Year:  2015        PMID: 26228108     DOI: 10.1245/s10434-015-4780-0

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  6 in total

1.  The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma: An Analysis of 1991 Patients.

Authors:  Morgan L Cox; Chi-Fu Jeffrey Yang; Paul J Speicher; Kevin L Anderson; Zachary W Fitch; Lin Gu; Robert Patrick Davis; Xiaofei Wang; Thomas A D'Amico; Matthew G Hartwig; David H Harpole; Mark F Berry
Journal:  J Thorac Oncol       Date:  2017-01-08       Impact factor: 15.609

2.  Extending the survival advantage of ground glass.

Authors:  Fred Lee; Bryan M Burt
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

3.  What CT characteristics of lepidic predominant pattern lung adenocarcinomas correlate with invasiveness on pathology?

Authors:  Emily A Aherne; Andrew J Plodkowski; Joseph Montecalvo; Sumar Hayan; Junting Zheng; Marinela Capanu; Prasad S Adusumilli; William D Travis; Michelle S Ginsberg
Journal:  Lung Cancer       Date:  2018-02-03       Impact factor: 5.705

4.  Video-assisted thoracoscopic lobectomy versus open lobectomy in the treatment of large lung cancer: propensity-score matched analysis.

Authors:  Jeonghee Yun; Junghee Lee; Sumin Shin; Hong Kwan Kim; Yong Soo Choi; Jhingook Kim; Jae Il Zo; Young Mog Shim; Jong Ho Cho
Journal:  J Cardiothorac Surg       Date:  2022-01-08       Impact factor: 1.637

5.  Efficacy of Adjuvant Chemotherapy With Tegafur-Uracil in Patients With Completely Resected, Node-Negative NSCLC-Real-World Data in the Era of Molecularly Targeted Agents and Immunotherapy.

Authors:  Takehito Shukuya; Kazuya Takamochi; Hiroyuki Sakurai; Kiyotaka Yoh; Tomoyuki Hishida; Masahiro Tsuboi; Yasushi Goto; Yujin Kudo; Yasuhisa Ohde; Sakae Okumura; Masataka Taguri; Hideo Kunitoh
Journal:  JTO Clin Res Rep       Date:  2022-04-06

6.  Sub-solid lung adenocarcinoma in Asian versus Caucasian patients: different biology but similar outcomes.

Authors:  Natalie S Lui; Jalen Benson; Hao He; Bartlomiej R Imielski; Christian A Kunder; Douglas Z Liou; Leah M Backhus; Mark F Berry; Joseph B Shrager
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 3.005

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.